{"url":"https://lda.senate.gov/api/v1/filings/44924ebe-5022-4e2a-a36a-2bc80796a7b5/","filing_uuid":"44924ebe-5022-4e2a-a36a-2bc80796a7b5","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2022,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/44924ebe-5022-4e2a-a36a-2bc80796a7b5/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Beth Anne Cole","dt_posted":"2022-10-16T20:35:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 Valley Stream Parkway","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Malvern","registrant_state":"PA","registrant_zip":"19355","registrant":{"id":401106408,"url":"https://lda.senate.gov/api/v1/registrants/401106408/","house_registrant_id":null,"name":"NOVOCURE INC.","description":"Global oncology company w/a proprietary platform technology called Tumor Treating Fields.","address_1":"1550 Liberty Ridge Drive","address_2":"Suite 115","address_3":null,"address_4":null,"city":"Wayne","state":"PA","state_display":"Pennsylvania","zip":"19087","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 202-327-8100","dt_updated":"2026-07-16T09:10:06.255740-04:00"},"client":{"id":213758,"url":"https://lda.senate.gov/api/v1/clients/213758/","client_id":12,"name":"NOVOCURE INC.","general_description":null,"client_government_entity":null,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139210,"prefix":"ms","prefix_display":"MS.","first_name":"KATHERINE","nickname":"KATIE","middle_name":null,"last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry","new":false},{"lobbyist":{"id":139211,"prefix":"ms","prefix_display":"MS.","first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"HAAS","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Veteran Affairs Issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139210,"prefix":"ms","prefix_display":"MS.","first_name":"KATHERINE","nickname":"KATIE","middle_name":null,"last_name":"MEYER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139211,"prefix":"ms","prefix_display":"MS.","first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"HAAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}